EW Healthcare Partners

News, insights, analysis and data

EW Healthcare Partners overview

Stories about EW Healthcare Partners

Picture of the Company

Cognate acquires Cobra Biologics

Cognate BioServices has acquired UK and Sweden-based Cobra Biologics, an advanced therapy CDMO that specializes in providing manufacturing services for the plasmid DNA and viral vector. No financial terms were disclosed. Cognate's backers include EW Healthcare Partners.

Picture of the Company

EW Healthcare Partners raises $746.33m

The Houston-based growth equity firm closed its latest healthcare technology fund.

Picture of the Company

EW Healthcare invests in Cognate BioServices

EW Healthcare Partners has invested in Cognate BioServices. Financial terms weren’t announced. Cognate BioServices is a contract development and manufacturing organization.

Picture of the Company

EW Healthcare Partners racks up $745 mln for fund

EW Healthcare Partners has raised $745 million for its second growth equity fund, beating its $650 million target. Fund2a targets healthcare companies in the pharmaceutical, medical device, diagnostics and technology-enabled services sectors in the U.S. and in Europe.

Picture of the Company

TissueTech snags $82.25 mln

Miami-based TissueTech Inc, a provider of therapeutic solutions for the ocular surface, wounds, surgery and other applications, has raised $82.25 million in financing. EW Healthcare Partners led the round.

Picture of the Company

Venus Concept gathers $38 mln

Toronto-based Venus Concept Ltd, an aesthetic technology company, has secured $38 million in funding. EW Healthcare Partners led the round with participation from HealthQuest Capital and Madryn Asset Management.

Picture of the Company

Aesthetic tech provider Venus Concept wins $48 mln in funding

Toronto aesthetic technology company Venus Concept Ltd has raised $38 million in an equity investment. The transaction was led by EW Healthcare Partners and joined by HealthQuest Capital and Madryn Asset Management. As a result, EW Healthcare and HealthQuest will each receive one seat on the board. Founded in 2009, Venus Concept develops and makes non-invasive devices for the global medical aesthetics market. Led by CEO Domenic Serafino, it will use the funds raised to grow its subscription-based business model and continue to develop its products. The company secured $10 million /canada/2014/5/venus-concept-nets-10-mln-in-funding-from-longitude-capital/ from Longitude Capital in 2014.

EW Healthcare Partners contact information

Offices

marker icon21 Waterway Avenue Suite 225, The Woodlands, Houston, 77380, United States
Showing 1 of 3 EW Healthcare Partners offices

Contacts

NameJob titleLocationEmail
Key Contact
user imageMs. Anne DeMaret
Job titleInvestor Relations Professional
LocationHouston, United States
Emaillock image-----------
user imageMr. Scott Barry
Job titleChief Operating Officer and Managing Director
LocationNew York, United States
Emaillock image--------
user imageMr. Greg Hill
Job titleChief Financial Officer and Chief Compliance Officer
LocationHouston, United States
Emaillock image---------
user imageDr. Evis Hursever
Job titleChief Executive Officer and Managing Director
LocationLondon, United Kingdom
Emaillock image------

Stories that mention EW Healthcare Partners

NY-based Invidia Capital Management adds third partner in two months

Until July, the healthcare-focused firm’s sole partner was its founder, the former global head of healthcare private investing at Goldman Sachs

Grooming tech to keep hospitals clean

A bevy of start-ups in recent years have emerged to help disinfect all aspects of hospitals, from handwashing to patient rooms to healthcare devices. This seemed like a novel idea before covid-19, but it’s essential now.

Cognate Bioservices takes in Series B, also buys Cobra Biologics

Cognate Bioservices, a contract development and manufacturing organization specializing in cell and cell-mediated gene therapy products, has closed its Series B funding round.

Dental tech company rakes in $85 mln

Sonendo, a dental tech company, has secured $85 million in funding.

Encore Dermatology secures $20 mln from Horizon

Horizon has provided a $20 million venture loan facility to Encore Dermatology. Headquartered in Malvern, Pennsylvania, Encore Dermatology is a specialty dermatology company. Encore is backed by EW Healthcare Partners, 1315 Capital and Longitude Capital.

Cota attracts $40 mln Series C

New York City-based Cota Inc, a healthcare real-world evidence and data analytics company, has raised $40 million in Series C financing. IQVIA led the round with participation from other investors that included EW Healthcare Partners.

Venture-backed Venus Concept to buy NeoGraft Solutions

Toronto-based aesthetic technology company Venus Concept Ltd has agreed to buy the hair restoration business of Lewisville, Texas-based NeoGraft Solutions. No financial terms were disclosed for the deal, which is expected to close this month. Venus Concept said the acquisition will broaden its customer base and product portfolio and spur growth plans for 2018. Founded in 2009, Venus Concept last year raised about $48 million in a financing /canada/2017/07/3462602/ led by EW Healthcare Partners and joined by HealthQuest Capital and Madryn Asset Management. It is also backed by Longitude Capital.